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Macrophages and b-cells are responsible for
CXCR2-mediated neutrophil infiltration of the
pancreas during autoimmune diabetes
Julien Diana1,2,* & Agnès Lehuen2,3,4
Abstract
Autoimmune type 1 diabetes (T1D) development results from
the interaction between pancreatic b-cells, and the innate and
the adaptive immune systems culminating with the destruction
of the insulin-secreting b-cells by autoreactive T cells. This
diabetogenic course starts during the first postnatal weeks by
the infiltration of the pancreatic islets by innate immune cells
and particularly neutrophils. Here, we aim to determine the
cellular and molecular mechanism leading to the recruitment of
this neutrophils in the pancreatic islets of non-obese diabetic
(NOD) mice. Here, we show that neutrophil recruitment in the
pancreatic islets is controlled by inflammatory macrophages and
b-cells themselves. Macrophages and b-cells produce the chemo-
kines CXCL1 and CXCL2, recruiting CXCR2-expressing neutrophils
from the blood to the pancreatic islets. We further show that
pancreatic macrophages secrete IL-1b-inducing CXCR2 ligand
production by the b-cells. Finally, the blockade of neutrophil
recruitment at early ages using CXCR2 antagonist dampens the
diabetogenic T-cell response and the later development of auto-
immune diabetes, supporting the therapeutic potential of this
approach.
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Introduction
Type 1 diabetes (T1D) is an autoimmune disorder engendered by
the deleterious actions of several cell types from both the innate and
the adaptive immune systems (Lehuen et al, 2010). We have
recently revealed using the non-obese diabetic (NOD) mouse model
that autoimmune diabetes is initiated in the pancreatic islets during
the first postnatal weeks and requires the crosstalk between various
innate immune cells including plasmacytoid dendritic cells (PDCs),
B-1a cells, and neutrophils (Diana et al, 2013). We have shown that
in neonatal NOD mice, neutrophils transiently infiltrate the pancre-
atic islets, produce the cathelicidin-related antimicrobial peptide
(CRAMP), and participate with the B-1a cells to the stimulation of
IFN-a-secreting pDCs in the pancreatic islets. This innate cell inter-
play is critical for diabetes development likely by the activation of
conventional DCs (cDCs) and their migration to the lymph nodes
where they present b-cell antigens to the autoreactive T cells
(Atkinson et al, 2014). However, one important question remains:
How neutrophils are recruited in the pancreatic islets of neonatal
NOD mice? The infiltration of immune cells in the pancreatic islets
during the T1D development has been extensively investigated
revealing a role for CCR2 and CCR5 on myeloid cells and a role for
CXCR3 and CCR5 on lymphoid cells (Eizirik et al, 2009). As
neutrophils have been identified only recently in the pancreatic
islets of neonatal NOD mice (Diana et al, 2013), the chemokines
and chemokine receptor(s) implicated in their recruitment remained
to determine. Various studies have demonstrated that neutrophil
trafficking is a tightly regulated phenomenon from the release of
neutrophils from the bone marrow (BM) into the circulation and
then into the inflamed tissues (Sadik et al, 2011; Kolaczkowska &
Kubes, 2013). The chemokines responsible for the recruitment of
neutrophils in the tissue can be produced by both immune and non-
immune cells such as macrophages and fibroblasts, respectively (Sa-
dik et al, 2011). Various studies have shown that murine and
human b-cells are able to produce various chemokines under
inflammatory conditions participating to the recruitment of immune
cells (Eizirik et al, 2009; Ortis et al, 2010; Sarkar et al, 2012). In this
study, we hypothesized that b-cells may play a direct role in the
recruitment of neutrophils in the pancreatic islets of neonatal NOD
mice, leading to T1D development.
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Results
Neutrophils infiltrate the pancreatic islets of neonatal NOD mice
In this study, we have investigated the mechanism of recruitment
of the neutrophils in the pancreatic islets of neonatal autoimmune
NOD mice. Kinetic analysis revealed that neutrophils (CD45+
CD11b+ Ly6G+) infiltrated the pancreatic islets at 2 weeks of age
and their frequency and absolute number increased until 3 weeks
of age specifically in the NOD mice while neutrophils were unde-
tectable in the islets of non-autoimmune C57BL/6 and BALB/c
mice (Fig 1A and Supplementary Fig S1A). Strikingly, in the
blood, a transient neutropenia was observed between 2 and
3 weeks of age in the NOD mice while neutrophil frequency and
absolute number remained unaffected in the two non-autoimmune
mice (Fig 1A and Supplementary Fig S1A). It is noteworthy that
the frequency and absolute number of circulating neutrophils at
any ages was higher in the NOD mice compared with the C57BL/
6 and BALB/c mice (Fig 1A and Supplementary Fig S1A).
Together, these data support that during the first postnatal weeks,
some neutrophils were recruited to the pancreatic islets of the
NOD mice and not in the pancreatic islets of the non-autoimmune
mice.
Circulating neutrophils harbor a mature phenotype in NOD mice
Neutrophil trafficking in mice is mainly regulated by two chemokine
receptors: CXCR2 and CXCR4 (Eash et al, 2009, 2010; Sadik et al,
2011; Sanz & Kubes, 2012). High CXCR4 expression retains imma-
ture neutrophils in the BM while high CXCR2 expression and the
presence of its ligands (mainly CXCL1 and CXCL2) allow the mobili-
zation of mature neutrophils in the blood and their subsequent
recruitment at inflamed sites. We observed that in the NOD mice,
circulating neutrophils harbor a higher expression of CXCR2 and
BM-neutrophils harbor a lower expression of CXCR4 as compared
with their respective counterparts from non-autoimmune mice
(Fig 1B and C). Accordingly, circulating NOD neutrophils harbored
a more mature phenotype (CD11bhigh and CD62Llow) as compared
with circulating neutrophils from non-autoimmune mice (Supple-
mentary Fig S2). In the pancreatic islets, NOD neutrophils harbored
a weak expression of CXCR4 and a mild expression of CXCR2 as
expected for activated neutrophils (Tikhonov et al, 2001), and addi-
tionally, the exposure of the chemokine receptor to its ligands in the
tissue would lead to receptor internalization and degradation
(Baugher & Richmond, 2008). These data support that circulating
NOD neutrophils harbored a mature phenotype likely favoring their
recruitment from the blood to the inflamed islets.
CXCR2 is required for the recruitment of neutrophils in the
pancreatic islets
To investigate the role of CXCR2 in the recruitment of neutrophils in
the pancreatic islets, we took advantage of the SB225002 molecule,
a potent CXCR2 antagonist (White et al, 1998). After treatment in
neonatal NOD mice, we observed that while CXCR2 blockade did
not affect the frequency and absolute number of neutrophils in the
BM, SB225002-treatment strongly prevented their recruitment from
the blood to the pancreatic islets of 3-week-old NOD mice (Fig 2A
and Supplementary Fig S1B). To confirm this result, we used the
b-cell-specific toxic drug streptozotocin (STZ) that triggers a rapid
recruitment of neutrophils to the pancreatic islets of 6-wk-old NOD
mice (Diana et al, 2013). As expected, STZ injection induced an
increased frequency and number of pancreatic neutrophils associ-
ated with a decreased frequency and absolute number of circulating
neutrophils (Fig 2B). Importantly, this neutrophil trafficking was
abrogated by CXCR2 blockade without affecting the recruitment of
the other immune cells in the islets of STZ-treated mice (Supplemen-
tary Fig S3). We also observed in vitro that the addition of STZ to
islet culture increased the production of CXCR2 ligands by the
pancreatic islets, suggesting that b-cell stress induces chemokine
release by the b-cells (Supplementary Fig S4). To exclude non-
specific effect of the systemic injection of SB225002, we performed
adoptive transfer experiments with neutrophils treated ex vivo with
SB225002. CFSE-labeled neutrophils were treated ex vivo with
SB225002, while FarRed-labeled neutrophils remained untreated
before cotransfer in 6-week-old NOD mice. Then, NOD mice were
treated with STZ, and we observed a decreased frequency and abso-
lute number of FarRed+-untreated neutrophils among the blood
neutrophil population and an increased frequency and absolute
number of these cells among the newly recruited pancreatic neutro-
phil population (Fig 2C and Supplementary Fig S1C). On the
contrary, CFSE+ SB225002-treated neutrophils failed to migrate
from the blood to the pancreatic islets. We repeated these experi-
ments using the reverse labeling to control for differential effects of
dyes and obtained similar results (Supplementary Fig S5). Finally, a
role for CCR1 in neutrophil recruitment to the pancreatic islets
appeared unlikely as we failed to detect its ligands (CCL3 and CCL5)
at 2 or 3 weeks of age in NOD mice (Supplementary Fig S6). Alto-
gether, these data support a critical role for CXCR2 on the recruit-
ment of neutrophils from the blood to the pancreatic islets in
neonatal NOD mice.
Neutrophil recruitment in the pancreatic islets is mediated by
CXCR2 ligands
We next investigated whether CXCL1 and CXCL2 can be responsible
for the neutrophil recruitment in the pancreatic islets as these
chemokines are two high-affinity ligands of CXCR2 in mice (Eash
et al, 2010; Schall & Proudfoot, 2011). Handpicked islets from
3-week-old NOD, C57BL/6 or BALB/c mice and from 6-week-old
NOD mice were cultured, and the concentration in CXCR2 ligands in
the islet-conditioned media was measured. We observed signifi-
cantly higher amount of CXCL1 and CXCL2 released by the pancre-
atic islets from 3-week-old NOD mice compared with pancreatic
islets from the two non-autoimmune mice or from 6-week-old NOD
mice (Fig 3A and B). We next performed in vitro migration assays
using blood neutrophils and islet-conditioned media as chemoattrac-
tant. As expected, blood neutrophils were efficiently attracted by
rmCXCL2 and this migration was significantly abrogated by pretreat-
ment of the neutrophils with CXCR2 antagonist (Fig 3C and Supple-
mentary Table S1). Using islet-conditioned media, we observed that
the migration of neutrophils was significantly higher using pancre-
atic islets from 3-week-old NOD mice compared with islets from
6-week-old NOD mice (Fig 3D and Supplementary Table S1). This
migration was abrogated using SB225002-pretreated neutrophils or
by the addition of antibodies against CXCL1 or CXCL2 in the
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Figure 1. Neutrophil phenotype in neonatal NOD mice.
A Kinetic analysis of neutrophils in the pancreatic islets, blood and spleen of female NOD, C57BL/6, and BALB/c mice. Cells were harvested at various age and stained
for CD45, CD11b, and Ly6G expressions. Frequency of neutrophils among CD45+ cells is represented. Data are representative (flow cytometry dot plot) or are
median  interquartile range from six independent experiments with three pooled mice for each group. UD: undetectable.
B, C Analysis of CXCR4 and CXCR2 expressions on neutrophils in 3-week-old mice. Cells from the pancreatic islets, blood, and bone marrow (BM) were recovered from
female NOD, C57BL/6, and BALB/c mice and stained for CD45, CD11b, Ly6G, CXCR4, and CXCR2 expressions. The frequency and mean fluorescence intensity (MFI) of
CXCR4 and CXCR2 on neutrophils are represented. Data are representative (B) or are median  interquartile range (C) from three independent experiments with
two independent mice for each group. ND: not determined.
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Figure 2. Neutrophils recruitment in the pancreas is dependent on CXCR2.
A Female NOD mice were treated or not between 1 and 3 weeks of age with the CXCR2 antagonist SB225002 (4 injections). Three days after the last treatment, cells
were recovered from the pancreatic islets, BM, and blood and stained for CD45, CD11b, and Ly6G expressions. Frequency of neutrophils among CD45+ cells is
represented. Data are representative (flow cytometry dot plot) or are median  interquartile range (scatter plot) from three independent experiments with two
independent pools of 2 mice for each group.
B Six-week-old female NOD mice were treated with SB225002 and, 12 h later, injected with streptozotocin (STZ). Twelve hours later, cells were harvested from the
pancreatic islets and blood, and neutrophil frequency and absolute number among CD45+ population were measured. Data are representative (flow cytometry dot
plot) or are median  interquartile range (scatter and histogram plots) from three independent experiments with two independent mice for each group.
C Neutrophils were sorted from the BM of 6-week-old female NOD mice, and cells were treated ex vivo or not with SB225002. Then, treated and untreated neutrophils
were stained with Cell trace® CSFE or FarRed, respectively, and cotransferred in 6-week-old NOD mice. Twelve hours after transfer, mice were injected with STZ, and
12 h after, cells were harvested from the pancreatic islets and blood and stained for CD45, CD11b, and Ly6G expressions. Data represented the frequency of
transferred neutrophils among the neutrophil population. Data are representative (flow cytometry dot plot) or are median  interquartile range (scatter plot) from
eight independent experiments with four pooled mice for each group.
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islet-conditioned media; while pretreatment of neutrophils with the
FPRL1 antagonist (WRW4) did not affect their recruitment (Fig 3D).
Moreover, the neutrophil migration toward islet-conditioned
media was NOD-specific as islet-conditioned media from the two
non-autoimmune strains faintly attracted neutrophils (Fig 3E and
Supplementary Table S1). Altogether, these data support that CXCL1
and CXCL2 were specifically produced in the pancreatic islets of 3-
week-old NOD mice attracting neutrophils in vitro.
CXCL1 and CXCL2 are produced in vivo by both b-cells
and macrophages
To investigate the cell source of CXCR2 ligands in vivo, we
performed histological analysis of pancreas from neonatal NOD and
C57BL/6 mice. We focused our analyses on CXCL2 because in our
hands and as indicated by the manufacturer, the polyclonal anti-
body against mouse CXCL1 was not suitable for immunohistology.
CXCL2 was present within the pancreatic islets and mainly colocal-
ized with insulin, supporting that CXCL2 was produced by the
b-cells (Fig 4A). Importantly, the expression was higher in the NOD
mice compared with the C57BL/6 mice. As infiltrating immune cells
could also produce CXCL2, we analyzed, by immunocytology,
single-cell suspension from pancreatic islets of neonatal NOD mice.
CXCL2 was produced by most of the insulin+ b-cells but also by
some CD45+ immune cells (Fig 4B). We next performed flow
cytometry analysis (Fig 4C) and observed that the CD45 insulin+
b-cells highly expressed CXCL1 and CXCL2, confirming our immu-
nohistological data, and that among the CD45+ immune cells, only
macrophages (F4/80+ CD11b+) expressed CXCL1 and CXCL2 and
no other myeloid cells (F4/80 CD11b+) or lymphoid cells
(CD11b). Together, these data support that in the pancreatic islets
of neonatal NOD mice, CXCL1 and CXCL2 were produced by both
b-cells and macrophages.
IL-1b is required for the production of CXCR2 ligands in the
pancreatic islets
Then, we investigated the molecular pathway leading to the produc-
tion of CXCR2 ligands by the b-cells. We focused on IL-1b as this
proinflammatory cytokine stimulated the secretion of various
chemokines by murine or human b-cells (Chen et al, 2001; Piemonti
et al, 2002; Citro et al, 2012). We treated neonatal NOD mice with a
neutralizing anti-IL-1b mAb, and we observed a significant decrease
in the recruitment of neutrophils (Fig 5A) and in the production of
CXCR2 ligands in the pancreatic islets (Fig 5B). Accordingly, in vitro
neutrophil migration assays revealed that the chemotactic activity of
islet-conditioned media from anti-IL-1b mAb-treated NOD mice was
reduced compared with islet-conditioned media from isotype-treated
NOD mice (Fig 5C). It is noteworthy that IL-1b blockade did not
affect pancreatic infiltration by other myeloid cells at 3 weeks of age
(Supplementary Fig S7). We investigated the cell source of IL-1b in
the pancreatic islets of neonatal NOD mice, and among the CD45+
immune infiltrating cells, we noticed a high frequency of inflamma-
tory M1 macrophages (F4/80+ CD11b+ CD11c+ CD206) which
were not detected in the peritoneum (Fig 5D). As M1 macrophages
were known as proinflammatory cells, we analyzed their production
of pro-IL-1b and we observed that pancreatic macrophages
expressed significantly higher amount of pro-IL-1b compared with
peritoneal macrophages (Fig 5E). We have chosen to analyze pro-
IL1b expression by FACS analysis as it was technically difficult to
isolate enough pancreatic macrophages to measure the secretion of
the mature form of IL-1b by ELISA. These data support that in the
pancreatic islets of neonatal NOD mice, inflammatory macrophages
produced pro-IL-1b and that this cytokine was required for the
production of CXCR2 ligands and the recruitment of neutrophils.
IL-1b-secreting macrophages stimulate the production of CXCR2
ligands by the b-cells
To directly address the role of macrophages in the recruitment of
neutrophils in the pancreatic islets, we performed depleting experi-
ments using clodronate-liposome injection in neonatal NOD mice.
We observed that macrophage depletion resulted in a significant
reduction in immune cell infiltration, particularly of neutrophils,
associated with a decreased production of CXCR2 ligands in the
pancreatic islets (Fig 6A and B). Then, by flow cytometry analysis,
we observed that macrophage depletion strongly diminished the
expression of CXCL2 (frequency and MFI) by the insulin+ b-cells
(Fig 6C). To further show that pancreatic IL-1b-secreting macro-
phages stimulated the b-cells to produce CXCR2 ligands, we
performed in vitro experiments using the Min6 b-cell line cultured
in a Transwell system with macrophages isolated from the pancre-
atic islets or the peritoneum of 3-week-old NOD mice (Fig 6D). First,
we validated that Min6 b-cells expressed CXCL2 and that such
expression was increased by the presence of rmIL-1b (Supplemen-
tary Fig S8). We observed that macrophages and Min6 b-cells
cultured separately were able to produce low level of CXCR2
ligands. However, similarly to rmIL-1b, the addition of pancreatic
macrophages but not of peritoneal macrophages increased the
production of CXCR2 ligands in the b-cell culture (Fig 6D). As we
did not observed, by flow cytometry analysis, an increased expres-
sion of CXCL2 by pancreatic macrophages after culture with the
b-cells (Supplementary Fig S9), we concluded that the b-cells
were responsible for the increased production of chemokines
observed in the coculture with pancreatic macrophages. Finally,
these productions of CXCR2 ligands were abrogated by the addi-
tion of anti-IL1b mAb in the coculture. Altogether, our in vivo and
in vitro data strongly support that IL-1b released by pancreatic
macrophages stimulated the production of CXCR2 ligands by the
b-cells.
Blockade of neutrophil recruitment in the pancreatic islets
dampened T1D development
We have recently demonstrated that neutrophils participate to the
initiation of the diabetogenic process (Diana et al, 2013). We specu-
lated that the blockade of neutrophil recruitment into the pancreatic
islets would affect T1D development in NOD mice. We evaluated
the well-defined autoreactive CD8 T-cell response against the b-cell
antigen islet-specific glucose-6-phosphatase catalytic subunit-related
protein (IGRP)206-214 in 8-wk-old NOD mice that were previously
treated with SB225002 between 1 and 3 weeks of age. We observed
that early CXCR2 blockade led to a dramatic reduction in IFN-c+
IGRP206-214-reactive CD8
+ T cells within the islets (Fig 7A) and
accordingly, dampened the infiltration of the islets and the develop-
ment of autoimmune diabetes up to 40 weeks of age in the NOD
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Figure 3. NOD pancreatic islets recruit neutrophils in vitro via CXCL1 and CXCL2.
A, B Pancreatic islets were isolated from female NOD, C57BL/6, and BALB/c mice at 3 or 6 weeks of age and cultured for 5 days. Then, CXCL1 and CXCL2 productions
were measured by ELISA in the culture supernatants. Data are median  interquartile range from three independent experiments with two independent mice for
each group.
C–E Neutrophils were sorted from the blood of 6-wk-old female mice and used for in vitro migration assays toward various doses of rmCXCL2 (C), NOD-islet-
conditioned media (D) or NOD-, C57BL/6-, or BALB/c-islet-conditioned media (E). In some conditions, neutrophils were pretreated with SB225002 or WRW4 before
the migration assay (C, D), and in other conditions, neutralizing anti-CXCL1 or anti-CXCL2 pAbs were added in the islet-conditioned media (D). Data are migration
index calculated assigning a value of 1 to the number of migrating cells toward medium alone. Data are median  interquartile range from two (C), six (D), and
five (E) independent experiments.
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mice (Fig 7B and C). It is noteworthy that CXCR2 blockage at later
age (between 8 and 10 weeks of age) did not affect subsequent
diabetes development (Supplementary Fig S10). These data
support that the blockage of neutrophil recruitment in the islets
of neonatal NOD mice reduced the later development of T1D deve-
lopment.
A
B
C
Figure 4. b-cells and macrophages produce CXCL1 and CXCL2 in the pancreatic islet of neonatal NOD mice.
A Immunohistological analysis of pancreas from female NOD and C57BL/6 mice at 3 weeks of age. Pancreatic sections were prepared as described in Methods. Data are
representative of three independent experiments with 2 pancreases per experiment with 10 sections for each pancreas.
B Pancreatic islet cell suspension were isolated and fixed for immunocytological analysis. Representative data from four independent mice are shown (picture), and the
frequency of CXCL2+ cells among CD45+ or insulin+ cells is shown (histogram plot) (1,000 cells pooled from four pancreases were numbered). Data are representative
(picture) or are median  interquartile range (histogram plot) from four independent mice.
C Pancreatic islet cells were isolated from 3-week-old female NOD mice, and cells were incubated 5h in the presence of Brefeldin A before staining for CD45, CD11b, F4/
80 surface expressions and for insulin and CXCL1 or CXCL2 intracellular expressions. Data are the frequency of CXCL1+ or CXCL2+ cells and are median  interquartile
range from three independent experiments with 2 pools of 2 mice per group for each experiment.
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Figure 5. IL-1b is required for CXCR2 ligand production and neutrophil recruitment in the pancreatic islets.
A, B 10-day-old female NOD mice were treated with anti-IL1b mAb or isotype control, and 11 days after, pancreatic islets were analyzed for the presence of neutrophils
by flow cytometry (A) or for CXCR2 ligands production by ELISA after culture (B). Data are representative (flow cytometry dot plot) or are median  interquartile
range (scatter plot) from seven (A) or four (B) independent experiments with three pooled mice per group.
C Neutrophils were sorted from the blood of 6-wk-old female mice and used for in vitro migration assays toward islet-conditioned media from untreated or anti-
IL1b-treated 3-wk-old NOD mice. Data are median  interquartile range from four independent experiments.
D, E Pancreatic islet cells or peritoneal cells were isolated from female NOD mice at 3 weeks of age, and cells were stained for CD45, CD11b, F4/80, CD11c, CD206
surface expressions and for pro-IL-1b intracellular expression. The frequency of M1 macrophages (CD11b+, F4/80+, CD11c+ CD206) and the MFI of pro-IL-1b
expression among macrophage population is represented. Data are representative (flow cytometry dot plot) or are median  interquartile range (scatter plot) from
four independent experiments with 3 pooled mice per group.
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Discussion
We have recently reported that neutrophils play a major role in the
initiation of autoimmune diabetes in the NOD mice (Diana et al,
2013). Here, we demonstrate that the recruitment of neutrophils
from the blood to the pancreatic islets of NOD mice is dependent on
CXCR2. We further show that the two CXCR2 ligands CXCL1
and CXCL2 are produced by both pancreatic macrophages and the
b-cells. Furthermore, our data demonstrate that IL-1b secreted by
inflammatory macrophages stimulates the production of CXCR2
ligands by the b-cells. Importantly, the blockade of neutrophils
recruitment in the neonatal NOD mice using a CXCR2 antagonist
dampens the diabetogenic T-cell response, the insulitis, and the inci-
dence of diabetes. These data reveal a novel crosstalk between
inflammatory macrophages, b-cells, and neutrophils and support
that in an autoimmune-prone genetic background, the b-cells
A
C
D
B
Figure 6. Pancreatic macrophages stimulate CXCR2 ligand production by the b-cells.
A–C Macrophages were depleted by injection of clodronate liposomes or PBS liposomes (control) in female NOD mice between 1 and 3 weeks of age. Pancreatic islets
were analyzed for the presence of neutrophils by flow cytometry (A), the production of CXCR2 ligands after culture by ELISA (B), or the expression of CXCL2 by the
b-cells by flow cytometry (C). Data are representative (flow cytometry plot) or are median  interquartile range (histogram or scatter plot) from three independent
experiments each performed with two independent pools of three mice per group.
D Pancreatic IL-1b-producing macrophages stimulate CXCL1/2 production by b-cells ex vivo. Min6 b-cells and sorted pancreatic or peritoneal macrophages from
3-week-old female NOD mice were cocultured for 48 h in a Transwell system. CXCL1 and CXCL2 productions in the culture supernatant were measured by ELISA.
Data are median  interquartile range from four independent experiments.
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actively participate to their own demise by recruiting diabetogenic
neutrophils. The presence of neutrophils in the target tissue appears
as a common trait in the pathogenesis of various autoimmune or
autoinflammatory diseases (Mocsai, 2013). Importantly, our recent
findings in the NOD mice appear to be relevant to the human
disease as a recent publication shows that a peripheral neutropenia
precedes T1D onset in patients and that neutrophils are observed in
the islets of multi-organ donors with recent-onset T1D (Valle et al,
2013).
The trafficking of infiltrating immune cells during the develop-
ment of autoimmune diabetes has been investigated notably using
chemokine receptor knockout mice or transgenic animal overex-
pressing specific chemokine under the control of the insulin
promoter. Several chemokines has been detected in the pancreatic
islets during the progression of the disease, allowing the recruitment
of myeloid cells through CCR2 and CCR5 and of lymphoid cells
through CXCR3 and CCR5 (Eizirik et al, 2009). However, these
chemokine receptors are responsible for the recruitment of both
diabetogenic and protective cells as revealed by the reduced inci-
dence of diabetes observed in the CCR2/ NOD mice and the accel-
erated incidence in the CXCR3/ or the CCR5/ NOD mice
(Solomon et al, 2010; Yamada et al, 2012). Neutrophil trafficking
from the BM into the circulation and from the blood into the
inflamed peripheral tissue is a tightly controlled phenomenon avoid-
ing collateral tissue damage due to the release by activated
neutrophils of various toxic molecules (Sadik et al, 2011; Amulic
et al, 2012). CXCR2 ligands are critical for the recruitment of
neutrophils in the tissue, and depending on the pathological context,
other chemokine receptors also play a role (Sadik et al, 2011).
During autoantibody-induced arthritis, the recruitment of neutro-
phils in the inflamed joint requires a cascade of cytokines and
chemokines (LTB4, IL-1b, CCR1, and CXCR2 ligands) produced by
A
B
C
Figure 7. Early blockade of neutrophil recruitment dampens the diabetogenic process in the NOD mice.
A Analysis of CD8+ T cells specific for IGRP206–214 in 8-week-old female NOD mice after SB225002 treatment or vehicle between 1 and 3 weeks of age (4 injections).
Islets were harvested and cultured for 8 days, and cells were stimulated for 5 h with IGRP206–214 peptide. Values are the frequency of IFN-c
+ cells among CD8+ T cells.
Data are representative (flow cytometry dot plot) or are median  interquartile range (scatter plot) from three independent experiments with two independent mice
for each.
B Histological analysis of pancreatic islet sections stained with hematoxylin and eosin from 12-week-old female NOD mice treated or not with SB225002 between 1 and
3 weeks of age (n = 3 mice per group).
C Female NOD mice were treated with SB225002 or vehicle between 1 and 3 weeks of age (4 injections), and incidence of diabetes was followed. N = 16 mice/group.
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endothelial cells, synovial cells, and neutrophils themselves (Chen
et al, 2006; Kim et al, 2006; Chou et al, 2010; Sadik et al, 2011). In
our study, we demonstrate that the infiltration of the pancreatic
islets by the neutrophils requires CXCR2 and that its ligands CXCL1
and CXCL2 are produced in part by the b-cells in the target tissue.
One should consider that other chemokines targeting CXCR2 may be
produced by the b-cells and play additional role in the recruitment
of neutrophils in the pancreatic islets. A pioneer study has demon-
strated that mouse b-cells are directly responsible for the recruit-
ment of diabetogenic CXCR3+ T cells in a virally induced model of
T1D (Frigerio et al, 2002). We also observed that pancreatic macro-
phages produce CXCR2 ligands as previously described (Sadik et al,
2011, 2012). Importantly, we show that macrophages also produced
CXCR2 ligands in the pancreatic islets. To define the precise contri-
bution of each cell type in the production of CXCR2 ligands and in
the subsequent recruitment of neutrophils in the pancreatic islets, a
selective and conditional knocking out of these chemokines specifi-
cally in the b-cells may be a powerful tool.
We excluded a putative role for cathelicidin in neutrophil recruit-
ment (De et al, 2000), as blocking of its receptor (FPRL1) on
neutrophils using WRW4 antagonist did not affect their in vitro
recruitment. Importantly, a recent study has demonstrated a critical
role for CXCR2 in the rejection of islet graft both in alloxan-induced
diabetic BALB/c mice and in T1D patients (Citro et al, 2012). In
mice, the authors demonstrated that grafted islets produce CXCR1/2
ligands stimulating the recruitment of harmful polymorphonuclear
leukocytes in the transplanted islets and that CXCR1/2 blockade
delays islet rejection. In humans, they demonstrated that the
CXCR1/2 blockade improves islet transplantation outcome in T1D
patients. These data and ours strongly support that the targeting of
neutrophil recruitment via CXCR2 blockade may be therapeutically
pertinent to prevent pancreatic islet destruction during T1D develop-
ment or after islet transplantation.
We demonstrate that b-cells produce CXCR2 ligands in response
to IL-1b secreted by inflammatory macrophages. It has been
previously shown in both rodents and humans that b-cells are high
producers of chemokines in response to inflammatory cytokines
(Cardozo et al, 2003; Ehses et al, 2009; Jacobsen et al, 2009;
Sarkar et al, 2012). Indeed, b-cells are uniquely susceptible to
IL-1b as they harbor a higher expression of IL-1R1 compared with
other cells from various tissues (Boni-Schnetzler et al, 2009). In
our study, treatment with anti-IL1b mAb in neonatal NOD mice
dampens the production of CXCL1 and CXCL2 and the recruitment
of neutrophils into the pancreatic islets. Regarding the role of
neutrophils in the initiation of the disease, one could expect that
such IL-1b blockade at early ages may reduce the development of
diabetes in NOD mice. Remarkably, some authors have reported
that treatment with soluble IL-1 receptor or neutralizing anti-IL-1b
pAb prevents cyclophosphamide-induced diabetes in NOD mice
(Nicoletti et al, 1994; Cailleau et al, 1997). A recent study also
shows a synergistic reversal of diabetes in NOD mice with anti-
CD3 antibody and IL-1 blockade (Ablamunits et al, 2012).
However, other groups have shown that IL-1R deficiency only
slows the progression of spontaneous T1D in NOD mice and that
IL-1R antagonist treatment of diabetic NOD mice fails to reverse
the disease (Thomas et al, 2004). In our study, IL-1b blockade did
not affect pancreatic infiltration by other immune cells at 3 weeks
of age supporting that IL-1b is not the only cytokine responsible
for the pancreatic inflammation during T1D development. Paradox-
ically, we observed an only transient expression of CXCR2 ligands
in the neonatal NOD mice even though proinflammatory cytokines
remain present in the pancreatic islets of older NOD mice. One
could hypothesize that the b-cells produce various chemokines at
each step of T1D development according to the type of infiltrating
cells in the pancreatic islets. Moreover, it has been shown that
type I IFN dampens neutrophil recruitment and the production of
CXCR2 ligands in a septic peritonitis model and after influenza
virus infection (Shahangian et al, 2009; Kelly-Scumpia et al, 2010).
As we have previously showed that pancreatic neutrophils stimu-
late the production of type I IFN by pDCs (Diana et al, 2013), we
hypothesize that neutrophils could indirectly downregulate their
own recruitment into the pancreatic islets.
We demonstrate that in neonatal NOD mice, pancreatic islets
are infiltrated by inflammatory macrophages producing CXCR2
ligands and pro-IL-1b stimulating the production of CXCR2 ligands
by the b-cells. It has been described that macrophages are the first
cells to infiltrate the islets during diabetes development (Dahlen
et al, 1998). Indeed, during the first postnatal weeks, waves of
physiological b-cell death occur in rodents (Trudeau et al, 2000;
Mathis et al, 2001), pigs (Bock et al, 2003) and humans (Kassem
et al, 2000) leading to the recruitment of macrophages required to
eliminate cell debris. In the NOD genetic background, these
macrophages produce exaggerated amounts of inflammatory
cytokines leading to a persistent inflammation of the pancreas
(Stoffels et al, 2004). Remarkably, this genetic defect of macro-
phages has been also identified in human with monocytes isolated
from the blood of T1D patients (Devaraj et al, 2006; Bradshaw
et al, 2009).
Altogether, these data reveal a novel crosstalk in the pancreatic
islets between macrophages, b-cells, and neutrophils during the first
postnatal weeks in the NOD mice. This study provides a new exam-
ple that in an autoimmune-prone genetic background, pancreatic
b-cells actively participate to their own demise as recently discussed
by Atkinson et al (Atkinson et al, 2011).
Materials and methods
Mice and treatments
Female BALB/c, C57BL/6, and NOD mice were bred and housed in
specific pathogen-free conditions. For CXCR2 blocking, mice were
intraperitoneally (i.p.) injected with SB225002 (0.5 mg/kg, Calbio-
chem) or vehicle (PBS-1% ethanol) between 1 and 3 weeks of age
(4 injections). For induction of b-cell death, 6-week-old mice were
injected once i.p. with streptozotocin (80 mg/kg, Sigma) or vehi-
cle (citrate buffer) as previously described (Turley et al, 2003). For
IL-1b blocking, mice were injected i.p. with anti-IL-1b mAb
(0.2 mg/mouse, 01BSUR, Novartis Pharma AG) or isotype control
(rat IgG1) between 1 and 3 weeks of age (4 injections). To deplete
macrophages, mice were injected i.p. with 200 lL of clodronate- or
PBS-loaded liposomes (control) between 1 and 3 weeks of age
(4 injections) as previously described (Van Rooijen & Sanders,
1994) (from ClodronateLiposomes.com). All animal experimental
protocols were approved by the ethic committee for animal experi-
mentation (CEEA34.JD.046.12).
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Preparation of pancreatic islets
Pancreata were perfused with 3 mL of a solution of collagenase P
(1.5 mg/mL, Roche) and then dissected free from surrounding
tissues. Pancreata were digested at 37°C for 10 min. Digestion was
stopped by adding HBSS-5% FCS followed by extensive washes. For
flow cytometry analysis, islets were purified on a discontinuous
Ficoll gradient, and for islet cultures, islets were purified by hand-
picking to avoid contamination by exocrine tissue.
Flow cytometry
Single-cell suspensions were prepared from various tissues and were
stained for 30 min at 4°C after FccRII/III blocking in PBS containing
2% FCS, 0.5% EDTA, and 0.1% sodium azide. Surface staining was
performed with the following antibodies: anti-CD45 (eBioscience,
30-F11), -CD11b (eBioscience, M1/70), -Ly6G (BD, 1A8), -CXCR4
(eBioscience, 2B11), -CXCR2 (Biolegend, TG11), -F4/80 (eBio-
science, BM8), -CD11c (eBioscience, N418), and -CD206 (Biolegend,
C068C2) mAbs. For intracellular CXCL1, CXCL2, and pro-IL-1b
staining, cell suspension was incubated 5 h at 37°C with Brefeldin A
(Sigma). After fixation and permeabilization (BD Fix&Perm), cells
were stained with anti-mouse CXCL1 or CXCL2 pAbs (R&D) and F
(ab’)2 donkey anti-rabbit-PE pAb (eBioscience) or with anti-mouse
IL-1b Pro-form mAb (eBioscience, IL-1F2). For analysis of insulin+
cells, pancreatic islet cells were surface-stained with anti-CD45
mAbs, then after fixation and permeabilization (BD Fix&Perm), cells
were stained with anti-insulin pAb (Abcam) following by secondary
antibody staining (anti-guinea pig-AlexaFluor488 pAb, Invitrogen).
For measurement of diabetogenic CD8+ T-cell response, handpicked
islets were cultured for 7 days in the presence of rmIL-2 (R&D,
50 U/mL). Then isolated cells were stimulated for 4 h at 37°C with
bone marrow-derived DCs loaded with IGRP206–214 peptide in the
presence of Brefeldin A before surface staining with TCRb (eBio-
science, H57-597) and CD8 (BD, 53–6.7) mAbs and intracellular
staining with anti-IFN-c (eBioscience, XMG1.2) mAb. In all experi-
ments, dead cells were excluded using Fixable Viability Dye
(eBioscience). Stained cells were analyzed and/or sorted on a BD
FACS Aria II flow cytometer.
Neutrophil transfer
Neutrophils were isolated from the bone marrow (BM) of 6-week-old
NOD mice using cell sorting according to their positive expression of
CD45, CD11b, and Ly6G. The purity of sorted neutrophil population
was routinely between 98 and 99%. Then, neutrophils were treated
or not with SB225002 (100 nM) or diluent (PBS-1% ethanol) for 10
min at 37°C. After extensive washes, treated or untreated cells were
stained with CellTrace CFSE or FarRed (Invitrogen), respectively. A
mix (1:1) of treated and untreated neutrophils (total 20 x 106 cells)
was injected (i.v.) in 6-week-old NOD mice. Twelve hours after
transfer, mice were treated with streptozotocin or vehicle, and after
12 h, transferred cells were analyzed in the blood and the islets.
CXCL1 and CXCL2 measurements
CXCL1 and CXCL2 production was evaluated in handpicked islet
culture and in cell culture supernatants by ELISA according to the
manufacturer protocols (Sigma). One hundred islets were cultured
for 5 days in DMEM 10% FBS and 1% penicillin/streptomycin, and
cell-free supernatants were recovered after centrifugation.
In vitro migration assay
Neutrophils were isolated from the blood of 6-week-old NOD mice
using cell sorting according to the positive expression of CD45,
CD11b, and Ly6G. The purity of sorted neutrophil population was
routinely between 98 and 99%. Chemotaxis was assayed in 24-well
micro-chemotaxis chambers (Costar) using 5-lm PVP-free polycar-
bonate filter. Neutrophils (105 cells/100 lL) were allowed to
migrate toward various doses of rmCXCL2 (R&D), islet supernatant
(100 islets equivalent), or medium alone (final volume: 600 lL). In
some conditions, neutrophils were pre-treated with SB225002
(100 nM) or WRW4 (10 mM, Tocris) for 15 min at 37°C and
neutralizing anti-CXCL1 or anti-CXCL2 mAbs (100 lg/mL, R&D) or
rat IgG (100 lg/mL) as control was added to the islet supernatants
30 min prior to migration assay. After 4 h at 37°C, migrating cells
were recovered in the lower compartment of the chamber and
numbered by flow cytometry. Each sample was assayed in triplicate.
Results are expressed as migration index: number of migrating
neutrophils in a defined condition divided by the number of migrat-
ing neutrophils toward medium alone.
In vitro coculture of b-cells and pancreatic macrophages
Culture was performed using tissue culture inserts (0.2 lm). Sorted
pancreatic macrophages (2 x 104 cells, CD45+ CD11b+ F4/80+)
were added to the upper compartment, and 106 Min6 b-cells were
added in the lower compartment. In some conditions, Min6 b-cells
were stimulated by the addition of rmIL-1b (10 ng/mL, Miltenyi) in
the upper compartment. In some conditions, neutralizing anti-IL-1b
mAb (Novartis Pharma AG) was added in the lower compartment
(200 lg/mL). Cells were cultured for 2 days, the cell-free superna-
tant of the lower compartment was recovered, and CXCL1 and
CXCL2 productions were measured by ELISA.
Histology and cytology
Pancreases fromNODmicewere embedded in tissue-freezingmedium
(Jung) and stored at 20°C. Tissues were cut into 5-lm section in
cryostat (Leica). Frozen sections were fixed in cold acetone. The abil-
ity of islet-infiltrating cells to produce CXCL2 was assayed as follows.
Cells were seeded on SuperFrost Plus microscope slide (Menzel-
Glaser) at a concentration of 106 cells/mL for 1 h at 37°C in DMEM,
10% FBS and 1% penicillin/streptomycin. Then, cells were fixed and
then stained with anti-CXCL2 pAb (R&D) and anti-CD45-APC mAb
and then anti-insulin pAb, each for 30min. Afterwashing, second-step
reagents were applied: anti-rabbit-AlexaFluor555 and anti-guinea pig-
AlexaFluor488 pAbs (Invitrogen), respectively. Nucleuses were
stainedwith Hoechst. Image acquisition was performed on the Cochin
Imaging Facility using amicroscope Leica DMI6000.
Diabetes diagnosis and histology
NOD females were tested every week for diabetes. Overt diabe-
tes was defined as two positive urine glucose tests, confirmed
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by a glycemia > 200 mg dL1. Glukotest kit was purchased from
Roche. For histology analysis, paraffin-embedded sections were
cut and stained with hematoxylin–eosin. Insulitis severity was
scored with at least 40 islets per mouse analyzed from 12-week-
old mice.
Statistical analysis
Diabetes incidence was plotted according to the Kaplan–Meier
method. Incidences between groups were compared with the
log-rank test. For other experiments, reported values are median
 interquartile range as indicated. Comparison between medians
was performed using the nonparametric Mann–Whitney U-test. P
values < 0.05 were considered statistically significant. All data
were analyzed using GraphPad Prism v5 software.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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